You just read:

BioLineRx Reports Results of Phase 2 Study for BL-8040 Monotherapy in Stem Cell Mobilization for Allogeneic Bone Marrow Transplantation

News provided by

BioLineRx Ltd.

May 17, 2018, 09:00 ET